Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1957 1
1962 1
1963 1
1964 1
1965 3
1966 1
1967 1
1968 3
1969 2
1970 8
1971 10
1972 7
1973 4
1974 1
1975 4
1976 2
1977 6
1978 2
1979 4
1980 1
1981 7
1982 5
1983 10
1984 4
1985 12
1986 11
1987 14
1988 15
1989 15
1990 17
1991 15
1992 6
1993 23
1994 19
1995 19
1996 21
1997 25
1998 33
1999 30
2000 36
2001 53
2002 66
2003 74
2004 88
2005 99
2006 120
2007 120
2008 141
2009 150
2010 180
2011 175
2012 202
2013 245
2014 285
2015 251
2016 234
2017 263
2018 230
2019 289
2020 266
2021 321
2022 293
2023 36
Text availability
Article attribute
Article type
Publication date

Search Results

4,075 results
Results by year
Filters applied: . Clear all
Page 1
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.
Hsieh RC, Krishnan S, Wu RC, Boda AR, Liu A, Winkler M, Hsu WH, Lin SH, Hung MC, Chan LC, Bhanu KR, Srinivasamani A, De Azevedo RA, Chou YC, DePinho RA, Gubin M, Vilar E, Chen CH, Slay R, Jayaprakash P, Hegde SM, Hartley G, Lea ST, Prasad R, Morrow B, Couillault CA, Steiner M, Wang CC, Venkatesulu BP, Taniguchi C, Kim YSB, Chen J, Rudqvist NP, Curran MA. Hsieh RC, et al. Among authors: hsu wh. Sci Immunol. 2022 Jun 10;7(72):eabl9330. doi: 10.1126/sciimmunol.abl9330. Epub 2022 Jun 10. Sci Immunol. 2022. PMID: 35687697 Free PMC article.
Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma.
Xuan W, Hsu WH, Khan F, Dunterman M, Pang L, Wainwright DA, Ahmed AU, Heimberger AB, Lesniak MS, Chen P. Xuan W, et al. Among authors: hsu wh. Cancer Immunol Res. 2022 Jun 3;10(6):770-784. doi: 10.1158/2326-6066.CIR-21-0559. Cancer Immunol Res. 2022. PMID: 35413115 Free PMC article.
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study.
Rugo HS, Lerebours F, Ciruelos E, Drullinsky P, Ruiz-Borrego M, Neven P, Park YH, Prat A, Bachelot T, Juric D, Turner N, Sophos N, Zarate JP, Arce C, Shen YM, Turner S, Kanakamedala H, Hsu WC, Chia S. Rugo HS, et al. Among authors: hsu wc. Lancet Oncol. 2021 Apr;22(4):489-498. doi: 10.1016/S1470-2045(21)00034-6. Lancet Oncol. 2021. PMID: 33794206 Clinical Trial.
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.
Wang M, Yang JC, Mitchell PL, Fang J, Camidge DR, Nian W, Chiu CH, Zhou J, Zhao Y, Su WC, Yang TY, Zhu VW, Millward M, Fan Y, Huang WT, Cheng Y, Jiang L, Brungs D, Bazhenova L, Lee CK, Gao B, Xu Y, Hsu WH, Zheng L, Jänne PA. Wang M, et al. Among authors: hsu wh. Cancer Discov. 2022 Jul 6;12(7):1676-1689. doi: 10.1158/2159-8290.CD-21-1615. Cancer Discov. 2022. PMID: 35404393 Free PMC article.
Response.
Chen JY, Hsu WT, Liu MA, Yo CH, Su CH, Lee CC. Chen JY, et al. Among authors: hsu wt. Am J Crit Care. 2022 Jan 1;31(1):8-9. doi: 10.4037/ajcc2022925. Am J Crit Care. 2022. PMID: 34972852 No abstract available.
4,075 results